Trino Therapeutics, a drug development firm spun-out of Trinity College, Dublin’s (TCB) School of Pharmacy, has raised over €9m ($12m) series A funding.

The round was led by VC firm Fountain Healthcare Partners and charitable foundation the Wellcome Trust, a founding investor in Trino. Joining in participation are government agency Enterprise Ireland and investment vehicle Growcorp.

Trino is focused on the development of anti-inflammatory therapeutics which are derived from a Taiwanese fern, and promises a wide range of potential applications,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?